Related Experiment Video
Updated: Jun 8, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Stevens-Johnson syndrome and toxic epidermal necrolysis: what do we know?
Alfredo Tartarone1, Rosa Lerose
1Division of Oncology, Centro di Riferimento Oncologico della Basilicata, IRCCS Rionero in Vulture, PZ, Italy. tarta1@virgilio.it
Abstract:
Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS) are rare but severe cutaneous adverse reactions related to a variety of medications. Although rare, SJS and TEN have a significant impact on public health because of high mortality. Also, if the SJS/TEN physiopathology is still unclear, a specific immune response to one or more drugs is involved, constituting a form of delayed-type hypersensitivity. Patients with SJS/TEN are often critically ill; therefore, they must be admitted to hospitals capable of delivering critical care. Currently, no treatment modality has been established as standard for these patients; therefore, therapy is primarily supportive and symptomatic and involves a multidisciplinary approach.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Staphylococcal Skin Infections
Clinical Applications of Epidermal Stem Cells
Cytotoxic Edema: Pathophysiology
Drug Toxicity: Dose-Dependent Reactions
